Historial de carrera de Georges Rawadi
Antiguos cargos conocidos de Georges Rawadi.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CELYAD ONCOLOGY SA | Director/Miembro de la Junta | 27/04/2023 | 01/12/2023 |
| Director Ejecutivo | 27/04/2023 | 01/12/2023 | |
YSOPIA Biosciences SA
 YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Director/Miembro de la Junta | 01/03/2018 | 01/09/2021 |
| Director Ejecutivo | 01/03/2018 | 01/09/2021 | |
| CELYAD ONCOLOGY SA | Corporate Officer/Principal | 01/06/2014 | 23/03/2018 |
| CELLECTIS S.A. | Corporate Officer/Principal | - | - |
Formación de Georges Rawadi.
| ESSEC Business School | Graduate Degree |
Estadísticas
Internacional
| Francia | 5 |
| Bélgica | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CELYAD ONCOLOGY SA | Health Technology |
| CELLECTIS S.A. | Health Technology |
| Empresas privadas | 2 |
|---|---|
| Université Pierre et Marie Curie | Consumer Services |
YSOPIA Biosciences SA
YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Health Technology |
- Bolsa de valores
- Insiders
- Georges Rawadi
- Experiencia
